Cargando…

Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease

Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatment of depression and anxiety in Parkinson’s disease. The aims were to review the extant literature, specify a model of cognitive and behavioral maintenance factors in depression and anxiety in Parkins...

Descripción completa

Detalles Bibliográficos
Autores principales: Egan, Sarah J., Laidlaw, Ken, Starkstein, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923758/
https://www.ncbi.nlm.nih.gov/pubmed/26406124
http://dx.doi.org/10.3233/JPD-150542
_version_ 1782439752529608704
author Egan, Sarah J.
Laidlaw, Ken
Starkstein, Sergio
author_facet Egan, Sarah J.
Laidlaw, Ken
Starkstein, Sergio
author_sort Egan, Sarah J.
collection PubMed
description Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatment of depression and anxiety in Parkinson’s disease. The aims were to review the extant literature, specify a model of cognitive and behavioral maintenance factors in depression and anxiety in Parkinson’s disease and provide a guide to treatment. It is argued that treatment should take into account specific cognitive and behavioral maintaining factors. Symptoms of depression and anxiety are highly prevalent in Parkinson’s disease and therapists should consider how to augment the efficacy of CBT for patients with Parkinson’s disease. Cognitive and behavioral interventions can help people overcome some of the challenges in living with PD by maximizing wellbeing and overall quality of life.
format Online
Article
Text
id pubmed-4923758
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-49237582016-06-29 Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease Egan, Sarah J. Laidlaw, Ken Starkstein, Sergio J Parkinsons Dis Review Evidence is reviewed demonstrating that cognitive behavior therapy (CBT) is effective in the treatment of depression and anxiety in Parkinson’s disease. The aims were to review the extant literature, specify a model of cognitive and behavioral maintenance factors in depression and anxiety in Parkinson’s disease and provide a guide to treatment. It is argued that treatment should take into account specific cognitive and behavioral maintaining factors. Symptoms of depression and anxiety are highly prevalent in Parkinson’s disease and therapists should consider how to augment the efficacy of CBT for patients with Parkinson’s disease. Cognitive and behavioral interventions can help people overcome some of the challenges in living with PD by maximizing wellbeing and overall quality of life. IOS Press 2015-09-14 /pmc/articles/PMC4923758/ /pubmed/26406124 http://dx.doi.org/10.3233/JPD-150542 Text en IOS Press and the authors. All rights reserved https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Egan, Sarah J.
Laidlaw, Ken
Starkstein, Sergio
Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
title Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
title_full Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
title_fullStr Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
title_full_unstemmed Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
title_short Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson’s Disease
title_sort cognitive behaviour therapy for depression and anxiety in parkinson’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923758/
https://www.ncbi.nlm.nih.gov/pubmed/26406124
http://dx.doi.org/10.3233/JPD-150542
work_keys_str_mv AT egansarahj cognitivebehaviourtherapyfordepressionandanxietyinparkinsonsdisease
AT laidlawken cognitivebehaviourtherapyfordepressionandanxietyinparkinsonsdisease
AT starksteinsergio cognitivebehaviourtherapyfordepressionandanxietyinparkinsonsdisease